These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2206136

  • 1. Rat brain insulin degrading enzyme in insulin and thyroid hormones imbalances.
    Azam M, Gupta BL, Gupta G, Jain S, Baquer NZ.
    Biochem Int; 1990; 21(2):321-9. PubMed ID: 2206136
    [Abstract] [Full Text] [Related]

  • 2. Modulation of insulin receptors and catecholamines in rat brain in hyperthyroidism and hypothyroidism.
    Azam M, Baquer NZ.
    Biochem Int; 1990; 20(6):1141-8. PubMed ID: 2196058
    [Abstract] [Full Text] [Related]

  • 3. Modulation of insulin receptors and catecholamines in rat brain in hyperglycemia and hyperinsulinemia.
    Azam M, Gupta G, Baquer NZ.
    Biochem Int; 1990 Oct; 22(1):1-9. PubMed ID: 2282071
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling.
    Seta KA, Roth RA.
    Biochem Biophys Res Commun; 1997 Feb 03; 231(1):167-71. PubMed ID: 9070242
    [Abstract] [Full Text] [Related]

  • 5. [Insulin-like substance and insulin-degrading complex in hemolysates of human erythrocytes].
    Matuliavichius VA, Vareĭkis EI, Lashas LV.
    Biokhimiia; 1986 Feb 03; 51(2):278-84. PubMed ID: 3516229
    [Abstract] [Full Text] [Related]

  • 6. In vivo and in vitro effects of hyperglycemia on Na+ -K+, Ca+2, Mg+2-dependent ATPases activity in brain synaptosomes of aging rats.
    Torlińska K, Grochowalska A, Kupsz J, Skoracka J, Kojo S.
    J Physiol Pharmacol; 2006 Nov 03; 57 Suppl 7():145-58. PubMed ID: 17228102
    [Abstract] [Full Text] [Related]

  • 7. In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody.
    Hari J, Shii K, Roth RA.
    Endocrinology; 1987 Feb 03; 120(2):829-31. PubMed ID: 3026782
    [Abstract] [Full Text] [Related]

  • 8. Biological properties of an initial degradation product of insulin by insulin-degrading enzyme.
    Yonezawa K, Yokono K, Shii K, Hari J, Yaso S, Sakamoto T, Kawase Y, Akiyama H, Taketomi S, Baba S.
    Endocrinology; 1989 Jan 03; 124(1):496-504. PubMed ID: 2642422
    [Abstract] [Full Text] [Related]

  • 9. Covalent linkage of 125I-insulin to a cytosolic insulin-degrading enzyme.
    Shii K, Baba S, Yokono K, Roth RA.
    J Biol Chem; 1985 Jun 10; 260(11):6503-6. PubMed ID: 3888982
    [Abstract] [Full Text] [Related]

  • 10. Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82.
    Harada S, Smith RM, Hu DQ, Jarett L.
    Biochem Biophys Res Commun; 1996 Jan 05; 218(1):154-8. PubMed ID: 8573122
    [Abstract] [Full Text] [Related]

  • 11. Tissue-specific regulation of malic enzyme by thyroid hormone in the neonatal rat.
    Sood A, Schwartz HL, Oppenheimer JH.
    Biochem Biophys Res Commun; 1996 May 15; 222(2):287-91. PubMed ID: 8670197
    [Abstract] [Full Text] [Related]

  • 12. The expression of and insulin binding to cellular thyroid hormone binding protein, but not insulin degrading enzyme, is increased during 3T3-L1 adipocytes differentiation.
    Lee YH, Harada S, Smith RM, Friedman R, Jarett L.
    Biochem Biophys Res Commun; 1996 May 24; 222(3):839-43. PubMed ID: 8651932
    [Abstract] [Full Text] [Related]

  • 13. Metabolism of a mutant insulin by a receptor-mediated process and an insulin degrading enzyme.
    Kobayashi M, Iwasaki M, Watanabe N, Ishibashi O, Takata Y, Haruta T, Sasaoka T, Shigeta Y, Inouye K.
    Diabetes Res Clin Pract; 1986 May 24; 2(5):257-62. PubMed ID: 3536368
    [Abstract] [Full Text] [Related]

  • 14. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
    Yaso S.
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr 20; 64(4):289-302. PubMed ID: 3042472
    [Abstract] [Full Text] [Related]

  • 15. Studies on the insulin-degrading activity of rat liver plasma membranes.
    Scott GS, Thomas JH, Dron DI.
    Biochem Soc Trans; 1981 Feb 20; 9(1):127-8. PubMed ID: 6260545
    [No Abstract] [Full Text] [Related]

  • 16. Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
    Yonezawa K, Yokono K, Shii K, Hari J, Yaso S, Amano K, Sakamoto T, Kawase Y, Akiyama H, Nagata M.
    Biochem Biophys Res Commun; 1988 Jan 29; 150(2):605-14. PubMed ID: 3277630
    [Abstract] [Full Text] [Related]

  • 17. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM, Bennett RG, Siford GL, Hamel FG.
    Biochem Pharmacol; 2009 Mar 15; 77(6):1064-73. PubMed ID: 19154729
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance].
    Li CZ, Zhang SH, Shu CD, Ren W.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb 15; 22(2):151-4. PubMed ID: 12390813
    [Abstract] [Full Text] [Related]

  • 19. Proteolytic degradation of insulin and glucagon in rat brain during ontogenesis.
    Reiser M, Bernstein HG, Ansorge S, Dorn A.
    Acta Histochem; 1987 Feb 15; 82(1):35-9. PubMed ID: 3122504
    [Abstract] [Full Text] [Related]

  • 20. [Insulin degradation in hepatocytes and erythrocytes of rats in normal condition and in experimental diabetes].
    Nikolaev SL, Strelkova MA, Komov VP.
    Vopr Med Khim; 2001 Feb 15; 47(3):329-37. PubMed ID: 11558315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.